Este sitio web está dirigido a profesionales sanitarios de España

En esta edición, destacados expertos han compartido investigaciones innovadoras que abordan el diagnóstico, tratamiento y manejo de diversas enfermedades lisosomales. 

Accede a los pósters clasificados por patologías y explora las videograbaciones de los autores, donde explican sus hallazgos más relevantes.

Gaucher y ASMD


Project for the education and diagnosis of Gaucher disease and acid sphingomyelinase deficiency (PREDIGA-2)


Clinical variability in Gaucher disease associated with the c.1880T>G (D409H) variant in GBA1


Efficacy of Eliglustat Administered With and Without Imiglucerase in Pediatric Participants With Gaucher Disease Type 1 or Type 3: The ELIKIDS Study


Predictive model for estimating the risk of bone mineral loss in Gaucher disease


Exploring the correlation between miRNA and osteonecrosis in Gaucher disease


Design of PROMs and PREMs questionnaire for ASMD care

1/6

Project for the education and diagnosis of Gaucher disease and acid sphingomyelinase deficiency (PREDIGA-2)


Clinical variability in Gaucher disease associated with the c.1880T>G (D409H) variant in GBA1


Efficacy of Eliglustat Administered With and Without Imiglucerase in Pediatric Participants With Gaucher Disease Type 1 or Type 3: The ELIKIDS Study


Predictive model for estimating the risk of bone mineral loss in Gaucher disease


Exploring the correlation between miRNA and osteonecrosis in Gaucher disease


Design of PROMs and PREMs questionnaire for ASMD care

1/2

Videograbaciones

Lisosomales


Lipid profiling in dried blood spots: A tool for diagnosing lysosomal storage disorders


Validation of "in silico" predictors for analyzing variants of uncertain significance in lysosomal storage disorders


Understanding the role of neutrophil extracellular traps in vascular complications of lysosomal disorders


Retrospective study to analyze and validate a set of potential predictive markers to identify lysosomal acid lipase deficiency


Evaluating lipocalin-2 as a biomarker for lysosomal acid lipase deficiency

1/5

Lipid profiling in dried blood spots: A tool for diagnosing lysosomal storage disorders


Validation of "in silico" predictors for analyzing variants of uncertain significance in lysosomal storage disorders


Understanding the role of neutrophil extracellular traps in vascular complications of lysosomal disorders


Retrospective study to analyze and validate a set of potential predictive markers to identify lysosomal acid lipase deficiency


Evaluating lipocalin-2 as a biomarker for lysosomal acid lipase deficiency

1/2

Videograbaciones

MPS


Long-term outcome of Mucopolysaccharidosis I-Hurler patients after hematopoietic cell transplantation


Oral therapy for lisosomal diseases

1/2

Long-term outcome of Mucopolysaccharidosis I-Hurler patients after hematopoietic cell transplantation


Oral therapy for lisosomal diseases

Videograbaciones

Neuromuscular


Successful desensitization protocol to alglucosidase and avalglucosidase alfa in a patient with infantile-onset Pompe disease


Reversible deficiencies of arylsulfatase B and alpha-galactosidase in Duchenne muscular dystrophy (DMD)

1/2

Successful desensitization protocol to alglucosidase and avalglucosidase alfa in a patient with infantile-onset Pompe disease


Reversible deficiencies of arylsulfatase B and alpha-galactosidase in Duchenne muscular dystrophy (DMD)

Videograbaciones

     

Mantente al tanto de todos los materiales del R@REVIEW 2025

MAT-ES-2500712 V1 ABRIL 2025